Leisure Capital Management Chimerix Inc Transaction History

Leisure Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 10, 2019	SELL	$2.05 - $4.32 $54,599 - $115,058	-26,634 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$1.79 - $3.12 $2,045 - $3,566	1,143 Added 4.48%	26,634 $56,000
Q4 2018 Feb 13, 2019	SELL	$2.24 - $3.9 $5,277 - $9,188	-2,356 Reduced 8.46%	25,491 $66,000
Q3 2018 Nov 09, 2018	BUY	$3.58 - $4.9 $99,692 - $136,450	27,847 New	27,847 $108,000
Q2 2018 Aug 02, 2018	SELL	$4.43 - $5.14 $125,125 - $145,179	-28,245 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$4.65 - $5.9 $2,483 - $3,150	-534 Reduced 1.86%	28,245 $147,000
Q4 2017 Feb 12, 2018	BUY	$4.32 - $5.52 $2,639 - $3,372	611 Added 2.17%	28,779 $133,000
Q3 2017 Oct 24, 2017	SELL	$4.35 - $5.25 $2,444 - $2,950	-562 Reduced 1.96%	28,168 $148,000
Q2 2017 Aug 09, 2017	BUY	N/A	28,730	28,730 $157,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Leisure Capital Management, based on Form 13F filings with the SEC.

Stay updated on Leisure Capital Management with notifications on news.